期刊文献+

saRNA调控p21基因表达对肝癌细胞的抑制作用 被引量:1

Study of targeting gene p21 by saRNA inhibits hepatocellular carcinoma cells
下载PDF
导出
摘要 目的探讨RNA激活p21对肝癌Hep G2、Hep 3b和SMMC-7721细胞生长和侵袭力的影响。方法化学合成靶向p21的saRNA,将其转染肝癌细胞系Hep G2、Hep 3b和SMMC-7721,利用荧光定量RT-PCR和免疫印迹检测细胞中的p21表达水平,并MTT法检测细胞生长情况及划痕实验观察细胞侵袭能力的变化。结果 Hep G2、Hep3b和SMMC-7721细胞的p21 mRNA分别较对照组升高了6.6、7.1、6.1倍,p21蛋白表达水平分别升高了17.4、11.4、6.7倍。细胞转染后48 h时的细胞增长平均抑制率分别为47%、53%和55%;划痕实验显示转染组细胞迁移能力显著低于对照组(P<0.01)。结论靶向p21的RNAa能抑制肝癌细胞的生长和侵袭力,p21可作为一个具有肝癌治疗应用价值的靶基因。 Objective To explore the effect of up- regulating expression p21 induced by saran on proliferation and invasion in hepatocellular carcinoma Hep G2,Hep 3b,SMMC- 7721 cells. Methods A saRNA,targeting gene p21 was synthesized. Hep G2,Hep 3b,SMMC- 7721 cells were cultured in vitro and transfected with saRNA,then RT- PCR and Western blotting were applied to detect the expression level of p21 mRNA and protein,respectively. The proliferation of the cells were analyzed by MTT kits. The invasion power of the cells were detected by scratch test. Results The p21 mRNA of Hep G2,Hep 3b,SMMC- 7721 cells were higher than the control group of 6. 6,7. 1,6. 1 times,respectively.And the p21 protein level were 17. 4,11. 4,6. 7 times,respectively. The three cells average inhibition rate were 47%,53% and 55%,respectively. In contrast to the blank control group,the cell migration activity of transfection group was declined( P〈0. 01). Conclusion RNAa targeting p21 can inhibit the proliferation and invasion power of Hep G2,Hep 3b,SMMC- 7721 cells. The p21 may be a target point of gene therapy for hepatocellular carcinoma.
出处 《临床和实验医学杂志》 2016年第10期929-933,共5页 Journal of Clinical and Experimental Medicine
基金 国家自然科学基金科学基金(81371597) 上海市卫生与计划生育委员会面上项目(20134090) 上海市浦东新区卫生与计划生育委员会重点专科建设项目(PWZz2013-02) 吴阶平医学基金(320.6750.14199) 上海市自然科学基金(13ZR1431900)
关键词 肝癌细胞 RNA激活 p21启动子 Hepatocellular carcinoma cells RNA activation p21 promoter
  • 相关文献

参考文献2

二级参考文献37

  • 1Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
  • 2He J, Gu DF, Wu XG, Reynolds K, Duan XF, Yao CH, et al. Major causes of death among men and women in China. N Engl J Med 2005; 353: 1124-34.
  • 3Hashem BE, Andrew CM. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-50.
  • 4Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology, 2005; 42: 1208-36.
  • 5Fire A, Xu SQ, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-11.
  • 6Eulalio A, Huntzinger E, Izaurralde E. Getting to the root of miRNA- mediated gene silencing. Cell 2008; 132: 9-14.
  • 7Paddison PJ, Caudy AA, Bernstein E ,Hannon G J, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002; 16: 948-58.
  • 8Morris KV, Chan SWL, Jacobsen SE, Looney DJ. Small interfering RNA- induced transcriptional gene silencing in human cells. Science 2004; 305: 1289-92.
  • 9Khraiwesh B, Asif MA, Seumel GI, Ossowski S, Weigel D, Reski R. Transcriptional control of gene expression by microRNAs. Cell 2010; 140: 111-22.
  • 10Li LC, Okino ST, Zhao H, Pookot D, Place RE, Urakami S, et al. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A 2006; 103: 17337-42.

共引文献7

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部